Live Feed

144 - BlackRock, Inc. (0002012383) (Subject)

Revenues of $2.05 billionNet income of $19 million, or $0.05 per shareAdjusted EBITDA* of $177 millionBookings of $520 million, representing a book-to-bill of 80%Returned $100 million of capital to shareholders through share repurchases and dividends *Free Cash Flow, Excess Free Cash Flow, Adjusted Operating Profit, and Adjusted EBITDA are non-GAAP measures, see "Non-GAAP Financial Measures," and "Reconciliation of GAAP to non-GAAP measures" below. HOUSTON, April 27, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE:NOV) today reported first quarter 2026 revenues of $2.05 billion, a decrease of two percent compared to the first quarter of 2025. Net income decreased $54 million, or $0.14 per dilu

Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review first quarter 2026 results. The conference call will be on Thursday, May 7, 2026 at 8:30 a.m. Eastern Time. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 4128483 Participants should dial in at least ten minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-r

ATHENS, Greece, April 27, 2026 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ:PSHG), ("we" or the "Company"), a global shipping company specializing in the ownership of tanker vessels, announced that it has filed its 2025 Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (the "Annual Report"), with the U.S. Securities and Exchange Commission (the "SEC"). The Annual Report, which contains the Company's audited consolidated financial statements, can be accessed through the SEC's website at http://www.sec.gov as well as through the Company's website at http://www.pshipping.com. Upon request, we will provide any shareholder with a hard copy of the Annual Report free

A 52% increase from baseline in mean C-peptide AUC at Week 12 in patients diagnosed within 0–3 years (n=5) receiving icovamenib 200 mg, with a clear dose response observed vs 100 mg (n=6)Persistence observed through Week 52, with mean C-peptide AUC largely preserved in 200 mg group (~7% decline from baseline) following only 12 weeks of dosingPreservation of C-peptide also observed in patients diagnosed between 3-15 years (n=9)Icovamenib was generally well tolerated across all dosing arms and demonstrated a favorable safety and tolerability profile through Week 52 Comprehensive dataset to be presented at the American Diabetes Association's (ADA) Scientific Sessions (abstract is preliminary un

DEF 14A - Revolution Medicines, Inc. (0001628171) (Filer)

8-K - Core Scientific, Inc./tx (0001839341) (Filer)

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ:INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announces that it has entered into amending agreements in respect of preferred investment options previously entered into with each of Sabby Volatility Warrant Master Fund, Ltd. ("Sabby") and certain affiliates of H.C. Wainwright & Co., LLC (the "Wainwright Parties").As previously reported: pursuant to the terms of the preferred investment options dated October 26, 2023 and June 26, 2025 (together, the "Sabby

CARY, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, May 11, 2026, at 8:30 a.m. ET to report first quarter 2026 financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the

8-K - Wheels Up Experience Inc. (0001819516) (Filer)

DEF 14A - GameSquare Holdings, Inc. (0001714562) (Filer)

8-K/A - ELECTRO SENSORS INC (0000351789) (Filer)

8-K - Velo3D, Inc. (0001825079) (Filer)

FWP - Veradermics, Inc (0001827635) (Subject)

FWP - INTEL CORP (0000050863) (Subject)

FWP - Blue Moon Metals Inc. (0001732379) (Subject)

SCHEDULE 13G/A - Cheer Holding, Inc. (0001738758) (Subject)

MILWAUKEE, April 27, 2026 /PRNewswire/ -- Louis Pinkham, Chief Executive Officer of Regal Rexnord Corporation (NYSE:RRX), announced that the Board of Directors, at its regular quarterly meeting held on April 27, 2026, declared a dividend of $0.35 per share. The dividend is payable on July 14, 2026, to shareholders of record at the close of business on June 30, 2026. The company has paid a dividend every quarter since January 1961. About Regal RexnordRegal Rexnord's 30,000 associates around the world help create a better tomorrow by providing sustainable solutions that power, transmit and control motion. The Company's electric motors and air moving subsystems provide the power to create motio

20-F - Metals Royalty Co Inc. (0002087398) (Filer)

DEFA14A - KKR & Co. Inc. (0001404912) (Filer)